MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on February 21, 2008; DOI: 10.1124/mol.107.043612


0026-895X/08/7306-1596-1609$20.00
Mol Pharmacol 73:1596-1609, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.107.043612v1
73/6/1596    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in MolPharm
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tao, J.
Right arrow Articles by Soong, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tao, J.
Right arrow Articles by Soong, T. W.

Activation of Corticotropin-Releasing Factor Receptor 1 Selectively Inhibits CaV3.2 T-Type Calcium ChannelsFormula

Jin Tao, Michael E. Hildebrand, Ping Liao, Mui Cheng Liang, Gregory Tan, Shengnan Li, Terrance P. Snutch, and Tuck Wah Soong

Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore (J.T., P.L., M.C.L., G.T., T.W.S.); Michael Smith Laboratories, University of British Columbia, Vancouver, Canada (M.E.H., T.P.S.); Department of Pharmacology, Nanjing Medical University, Nanjing, China (J.T., S.L.); and Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland (T.W.S.)

The corticotropin-releasing factor (CRF) peptides CRF and uro-cortins 1 to 3 are crucial regulators of mammalian stress and inflammatory responses, and they are also implicated in disorders such as anxiety, depression, and drug addiction. There is considerable interest in the physiological mechanisms by which CRF receptors mediate their widespread effects, and here we report that the native CRF receptor 1 (CRFR1) endogenous to the human embryonic kidney 293 cells can functionally couple to mammalian CaV3.2 T-type calcium channels. Activation of CRFR1 by either CRF or urocortin (UCN) 1 reversibly inhibits CaV3.2 currents (IC50 of ~30 nM), but it does not affect CaV3.1 or CaV3.3 channels. Blockade of CRFR1 by the antagonist astressin abolished the inhibition of CaV3.2 channels. The CRFR1-dependent inhibition of CaV3.2 channels was independent of the activities of phospholipase C, tyrosine kinases, Ca2+/calmodulin-dependent protein kinase II, protein kinase C, and other kinase pathways, but it was dependent upon a cholera toxin-sensitive G protein-mediated mechanism relying upon G protein β{gamma} subunits (Gβ{gamma}). The inhibition of CaV3.2 channels via the activation of CRFR1 was due to a hyperpolarized shift in their steady-state inactivation, and it was reversible upon washout of the agonists. Given that UCN affect multiple aspects of cardiac and neuronal physiology and that CaV3.2 channels are widespread throughout the cardiovascular and nervous systems, the results point to a novel and functionally relevant CRFR1-CaV3.2 T-type calcium channel signaling pathway.


Received November 19, 2007; accepted February 21, 2008

Address correspondence to: Dr. Tuck Wah Soong, Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597. E-mail: phsstw{at}nus.edu.sg


Related articles in MolPharm:

Making the T-Type Even Tinier: Corticotropin-Releasing Factor-Mediated Inhibition of Low-Voltage-Activated Calcium Channel Activity
Diego L. Varela, Tamara Hermosilla, and Gerald W. Zamponi
MolPharm 2008 73: 1589-1591. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
J. Neurosci.Home page
J. D. Graef, B. K. Nordskog, W. F. Wiggins, and D. W. Godwin
An Acquired Channelopathy Involving Thalamic T-Type Ca2+ Channels after Status Epilepticus
J. Neurosci., April 8, 2009; 29(14): 4430 - 4441.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Hu, S. D. DePuy, J. Yao, W. E. McIntire, and P. Q. Barrett
Protein Kinase A Activity Controls the Regulation of T-type CaV3.2 Channels by G{beta}{gamma} Dimers
J. Biol. Chem., March 20, 2009; 284(12): 7465 - 7473.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. L. Varela, T. Hermosilla, and G. W. Zamponi
Making the T-Type Even Tinier: Corticotropin-Releasing Factor-Mediated Inhibition of Low-Voltage-Activated Calcium Channel Activity
Mol. Pharmacol., June 1, 2008; 73(6): 1589 - 1591.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics